Insider Trading February 25, 2026

IBM Director Michelle J. Howard Makes Personal Share Purchase Worth $11,891

Small insider buy occurs as IBM stock trades near 52-week low amid mixed analyst views on mainframe and AI strategy

By Priya Menon IBM
IBM Director Michelle J. Howard Makes Personal Share Purchase Worth $11,891
IBM

IBM director Michelle J. Howard purchased 50 shares of International Business Machines Corp. on February 25, 2026, paying $237.83 per share for a total of $11,891. The trade leaves her with 194 shares directly held. The purchase takes place while IBM shares have fallen 19% year-to-date and recently edged down 7.3% over the prior week, trading close to a 52-week low of $214.50. Analysts remain divided on IBM's prospects, citing both mainframe strengths and competitive pressures in AI and modernization efforts.

Key Points

  • Director Michelle J. Howard bought 50 IBM shares on February 25, 2026, at $237.83 per share, totaling $11,891, and now directly holds 194 shares.
  • IBM stock has fallen 19% year-to-date and lost 7.3% in the past week, trading near a 52-week low of $214.50; the stock yields 2.83% and the company has raised its dividend for 30 straight years.
  • Analysts hold mixed stances: Morgan Stanley cut its price target to $247 (Equalweight), UBS moved to Neutral with a $236 target, while Wedbush, Evercore ISI, and Jefferies maintained more bullish ratings citing mainframe resilience and modernization efforts.

Michelle J. Howard, a director at International Business Machines Corp. (NYSE: IBM), reported acquiring 50 shares of the company's common stock on February 25, 2026. The position was opened at a purchase price of $237.83 per share, bringing the total value of the transaction to $11,891. Following the filing, Howard's direct holdings in IBM total 194 shares.

The timing of the purchase coincides with a broader weakness in IBM's equity. Year-to-date, the stock has slipped 19% and, over the most recent week, declined 7.3%. At the time of the report, the share price was trading near its 52-week low of $214.50.

Alongside the insider purchase, public company metrics highlighted in available research materials show IBM currently offering a dividend yield of 2.83%. The company has increased its dividend for 30 consecutive years, according to the InvestingPro analysis referenced in company filings and research summaries. For investors seeking expanded coverage, InvestingPro provides a Pro Research Report for IBM and more than 1,400 U.S. stocks.

Market participants and analysts continue to express differing views on IBM's trajectory. Morgan Stanley lowered its price target to $247 and kept an Equalweight rating, citing concerns related to AI disruption as a factor in its adjustment. In contrast, UBS moved its stance to Neutral from Sell and established a $236 price target, pointing to what it sees as a more balanced risk-reward profile.

Other firms offered more bullish targets while noting competitive dynamics. Wedbush reiterated an Outperform rating and maintained a $340 price target despite commentary about potential competition from Anthropic's Claude Code tool and the possible implications for systems built on COBOL. Evercore ISI continued to rate IBM Outperform, emphasizing the company's mainframe business and describing that franchise as an integrated platform that extends beyond COBOL code alone. Jefferies reaffirmed a Buy rating with a $370 price target, citing IBM's work to modernize legacy systems using tools such as watsonx Code Assistant for Z.

Collectively, the insider transaction and the range of analyst opinions underscore active investor focus on IBM's mix of legacy mainframe strength, dividend income characteristics, and the company's efforts to modernize using AI-related tooling. The purchase by a board member represents a modest personal investment relative to market capitalization but adds a datapoint to the ongoing market conversation about valuation and strategic direction.


Additional disclosure: InvestingPro analysis and Pro Research Reports were cited in company-related commentary and are available across 1,400+ U.S. stocks as noted in the referenced materials.

Risks

  • Competitive pressures in AI and new developer tools, such as Anthropic's Claude Code, could affect demand for certain IBM system workloads - impacts are noted for enterprise software and legacy systems sectors.
  • Market valuation uncertainty reflected in a 19% year-to-date share price decline and proximity to a 52-week low - this influences investor sentiment in the technology and financial markets.
  • Divergent analyst price targets and ratings introduce uncertainty around near-term price direction, affecting equity investors and those focused on enterprise IT and mainframe exposure.

More from Insider Trading

Fifth Third CIO Schramm Sells $757,514 in Stock After Exercising SARs; Bank Advances With Comerica Deal Feb 25, 2026 Avnet CEO Completes $3.1M Share Sale, Exercises Options for Equivalent Amount Feb 25, 2026 Verizon Director Hans Erik Vestberg Disposes $11.16M in Shares as Stock Near 52-Week High Feb 25, 2026 DT Midstream CFO Adds $25,221 in Stock; Company Posts Mixed Q4 Results Feb 25, 2026 Williams Companies General Counsel Disposes of $1.97M in Stock; Prior Option Exercise and Withholdings Reported Feb 25, 2026